Growth Metrics

bioAffinity Technologies (BIAF) Shares Outstanding (Diluted Average) (2022 - 2026)

bioAffinity Technologies has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $4.5 million for Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) rose 729.53% to $4.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Mar 2026, up 729.53% year-over-year, with the annual reading at $1.7 million for FY2025, 325.83% up from the prior year.
  • Shares Outstanding (Diluted Average) was $4.5 million for Q1 2026 at bioAffinity Technologies, up from $1.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $24.0 million in Q2 2025 and troughed at $374445.0 in Q3 2024.
  • The 5-year median for Shares Outstanding (Diluted Average) is $4.5 million (2022), against an average of $6.1 million.
  • Year-over-year, Shares Outstanding (Diluted Average) plummeted 95.69% in 2024 and then skyrocketed 729.53% in 2026.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $4.5 million in 2022, then surged by 94.43% to $8.7 million in 2023, then tumbled by 95.38% to $404167.0 in 2024, then surged by 325.83% to $1.7 million in 2025, then soared by 161.16% to $4.5 million in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Shares Outstanding (Diluted Average) are $4.5 million (Q1 2026), $1.7 million (Q4 2025), and $1.1 million (Q3 2025).